Feb 29 |
CareDx, Inc. (CDNA) Q4 2023 Earnings Call Transcript
|
Feb 29 |
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Feb 28 |
CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023
|
Feb 28 |
CareDx Non-GAAP EPS of -$0.17 beats by $0.10, revenue of $65.6M beats by $1.54M
|
Feb 28 |
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
|
Feb 27 |
CareDx Q4 2023 Earnings Preview
|
Feb 27 |
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
|
Feb 26 |
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics
|
Feb 21 |
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
|
Feb 21 |
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
|